Pitfalls in the Surgical Management of Undifferentiated Sarcoma of the Liver and Benefits of Preoperative Chemotherapy

Abstract

Aim Undifferentiated sarcoma of the liver (USL) is the third commonest malignant liver tumor in children. The aim of our study is to evaluate the outcome of this rare entity according to the quality of the surgical resection and the compliance to the European pediatric soft tissue sarcoma group guidelines.

Patients and Methods We conducted a monocentric review of patients referred to our department with a definitive pathologic diagnosis of USL between 1997 and 2013. We looked at the diagnosis and management pitfalls, surgical technique, and outcomes. Results are expressed as median (range).

Results There were 13 patients (M/F = 7:6 = 1.1). Age at presentation was 8 years (range, 11 months–16 years). Of the 13 patients, 10 patients (69%) presented with abdominal pain, 5 (38%) with tumoral bleeding, and 2 (15%) with peritoneal rupture. All lesions were unique, nonmetastatic, and heterogeneous with cystic components measuring 14 (6–19) cm. Six (46%) patients had an upfront surgery: five because of wrong clinical diagnosis (three query mesenchymal hamartoma, one spontaneous peritoneal bleeding, and one cystic lymphangioma), and one because of rapid enlargement of the mass. Seven (54%) patients (including one with tumoral bleeding) received neoadjuvant chemotherapy, and had their tumor diameter decreasing by 40% (range, 0–60%). Final surgery consisted of seven right hepatectomies; one right extended hepatectomy; three mesohepatectomies; two left hepatectomies. There were three incomplete resection in the upfront surgery group versus none in the neoadjuvant chemotherapy group. The degree of tumor necrosis after chemotherapy ranged from 95 to 100%. Surgical complications included the following: liver transplantation (LT) following a Budd–Chiari syndrome after a mesohepatectomy, one biliary ducts injury treated by Roux-en-Y loop. All patients received the postoperative chemotherapy according to the European protocol. One of seven patients (14%) with neoadjuvant chemotherapy underwent radiotherapy for rupture at diagnosis versus three of six patients (50%) with upfront surgery: one for rupture at diagnosis and two for rupture during upfront surgery. One patient (17%) with upfront surgery had local recurrence at 2 years after initial surgery, and is in second complete remission 1 year after a redo surgery. All patients are alive at a median 34 months (range, 5–134) follow-up.

Conclusion USL presents with painful mixed cystic and solid liver mass. If misdiagnosed and mistreated (enucleation or unroofing), the usual good outcome of this malignancy could be impaired. Preoperative chemotherapy is recommended.

Keywords

liver - undifferentiated sarcoma - children - chemotherapy - surgery

• References

• 1 Stocker JT, Ishak KG. Undifferentiated (embryonal) sarcoma of the liver: report of 31 cases. Cancer 1978; 42 (1) 336-348
• 2 Bisogno G, Pilz T, Perilongo G , et al. Undifferentiated sarcoma of the liver in childhood: a curable disease. Cancer 2002; 94 (1) 252-257
• 3 Chocarro G, Amesty MV, Hernández F , et al. Embryonal sarcoma of the liver. Pediatr Surg Int 2013; 29 (12) 1261-1266
• 4 Geel JA, Loveland JA, Pitcher GJ, Beale P, Kotzen J, Poole JE. Management of undifferentiated embryonal sarcoma of the liver in children: a case series and management review. S Afr Med J 2013; 103 (10) 728-731
• 5 Ismail H, Dembowska-Bagińska B, Broniszczak D , et al. Treatment of undifferentiated embryonal sarcoma of the liver in children—single center experience. J Pediatr Surg 2013; 48 (11) 2202-2206
• 6 Kim D-Y, Kim K-H, Jung S-E, Lee SC, Park KW, Kim WK. Undifferentiated (embryonal) sarcoma of the liver: combination treatment by surgery and chemotherapy. J Pediatr Surg 2002; 37 (10) 1419-1423
• 7 May LT, Wang M, Albano E, Garrington T, Dishop M, Macy ME. Undifferentiated sarcoma of the liver: a single institution experience using a uniform treatment approach. J Pediatr Hematol Oncol 2012; 34 (3) e114-e116
• 8 Plant AS, Busuttil RW, Rana A, Nelson SD, Auerbach M, Federman NC. A single-institution retrospective cases series of childhood undifferentiated embryonal liver sarcoma (UELS): success of combined therapy and the use of orthotopic liver transplant. J Pediatr Hematol Oncol 2013; 35 (6) 451-455
• 9 Walther A, Geller J, Coots A , et al. Multimodal therapy including liver transplantation for hepatic undifferentiated embryonal sarcoma. Liver Transpl 2014; 20 (2) 191-199
• 10 Upadhyaya M, McKiernan P, Hobin D , et al. Primary hepatic sarcomas in children—a single-center experience over 19 years. J Pediatr Surg 2010; 45 (11) 2124-2128
• 11 López-Terrada D, Alaggio R, de Dávila MT , et al. Towards an international pediatric liver tumor consensus classification: proceedings of the Los Angeles COG liver tumors symposium. Mod Pathol 2014; 27 (3) 472-491
• 12 Exelby PR, Filler RM, Grosfeld JL. Liver tumors in children in the particular reference to hepatoblastoma and hepatocellular carcinoma: American Academy of Pediatrics Surgical Section Survey—1974. J Pediatr Surg 1975; 10 (3) 329-337
• 13 Shehata BM, Gupta NA, Katzenstein HM , et al. Undifferentiated embryonal sarcoma of the liver is associated with mesenchymal hamartoma and multiple chromosomal abnormalities: a review of eleven cases. Pediatr Dev Pathol 2011; 14 (2) 111-116
• 14 Küpeli S, Yalçin B, Cil BE, Akçören Z, Büyükpamukçu M. Undifferentiated embryonal sarcoma of the liver in a child complicated by haemorrhage. Pediatr Radiol 2008; 38 (11) 1259-1261
• 15 Bölling T, Willich N, Ernst I. Late effects of abdominal irradiation in children: a review of the literature. Anticancer Res 2010; 30 (1) 227-231